Streetbeat News

LUCY

Innovative Eyewear, Inc.

https://www.lucyd.co

Industry

Medical - Instruments & Supplies

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. The company sells its products through various e-commerce and retail distribution channels. Innovative Eyewear, Inc. has a partnership with Lucyd. The company was founded in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. operates as a subsidiary of Lucyd Ltd.

Open

6.80

Mkt cap

16M

Volume

96K

High

7.13

P/E Ratio

-0.63

52-wk high

27.20

Low

6.70

Div yield

N/A

52-wk low

3.26

Innovative Eyewear, Inc. (NASDAQ:LUCY) shares are surging on heavy trading volume despite no new company-specific news. The stock has seen over 615 million shares traded, far exceeding its 100-day average volume of 368,000 shares. Last week, the company reported first-quarter GAAP losses of 15 cents per share, beating analyst estimates, but missed revenue expectations. Analysts have a 12-month price target of $1 for the stock, which is currently up 374% to 88 cents.

Portfolio Pulse from Erica Kollmann

May 24, 2024 | 5:13 pm

The article highlights significant intraday movements in health care stocks on Friday. Notable gainers include Innovative Eyewear (LUCY), OneMedNet (ONMD), TransCode Therapeutics (RNAZ), Onconetix (ONCO), Aptorum Group (APM), and Immatics (IMTX). Major losers include Verastem (VSTM), Sensei Biotherapeutics (SNSE), Genelux (GNLX), Exicure (XCUR), TriSalus Life Sciences (TLSI), and HOOKIPA Pharma (HOOK).

Portfolio Pulse from Benzinga Insights

May 24, 2024 | 4:31 pm

The article highlights the pre-market movements of 12 health care stocks on Friday. Notable gainers include Cue Health (HLTH), Innovative Eyewear (LUCY), SCWorx (WORX), Arcus Biosciences (RCUS), Biora Therapeutics (BIOR), and Jin Medical International (ZJYL). Significant losers include Verastem (VSTM), Sensei Biotherapeutics (SNSE), Genelux (GNLX), Summit Therapeutics (SMMT), Akari Therapeutics (AKTX), and Akso Health Group (AHG).

Portfolio Pulse from Benzinga Insights

May 24, 2024 | 12:07 pm

Innovative Eyewear announced plans to launch new features for its Lucyd App in 2024, including a paid 'Pro' version. This move is expected to create an additional revenue stream from its glasses customers.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 12:43 pm

Innovative Eyewear (LUCY) reported Q1 2024 earnings with a GAAP EPS of $(0.15), surpassing the $(0.17) estimate, but missed sales estimates with $383.471K against the expected $700.000K. This represents a 164.61% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 12:41 pm

In Monday's after-market session, several healthcare stocks showed notable movements. Agape ATP, FibroGen, RxSight, Innovative Eyewear, Hims & Hers Health, and iSpecimen were among the gainers, with significant increases in their share prices, attributed to factors like Q1 earnings reports. Conversely, Predictive Oncology, SI-BONE, Anitra, Ontrak, Clene, and Regulus Therapeutics experienced declines. The movements reflect the market's reaction to recent earnings reports and other company-specific news.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 8:31 pm

In Tuesday's intraday session, several health care stocks experienced significant movements. Akili, Cyclacel Pharmaceuticals, Eliem Therapeutics, GeneDx Hldgs, Dare Bioscience, and Lucid Diagnostics were among the gainers, with Akili leading at a 70.1% increase. On the downside, NRX Pharmaceuticals, Innovative Eyewear, Vaxxinity, Barinthus Biotherapeutics, Annovis Bio, and OpGen saw notable declines, with NRX Pharmaceuticals dropping by 23.9%.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 4:31 pm

Innovative Eyewear Inc (NASDAQ:LUCY) shares dropped 19% to $0.195 after announcing a direct offering of 4,200,822 shares at $0.244 each, along with equal unregistered warrants, aiming to raise about $1.025 million for working capital and general purposes. The offering is expected to close by May 1. Over the past year, LUCY shares have plummeted by 91.23%, with a significant loss for investors who bought at the beginning of the year or on March 1. The stock's all-time high is $5.89, and it currently has a neutral RSI of 42.52.

Portfolio Pulse from Henry Khederian

April 30, 2024 | 4:27 pm

Innovative Eyewear's stock trades lower following the announcement of a $1.025 million registered direct offering.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 4:26 pm

Innovative Eyewear, Inc. has partnered with New Look Vision Group to offer its Lucyd smart eyewear in Canada. The smart frames are available on NewLook.ca and select stores in Quebec. New Look, a leading eyewear retailer with over 450 stores in the US and Canada, has been recognized as one of Canada's Best Managed Companies. This partnership allows Innovative Eyewear to introduce its products to the Canadian market, leveraging New Look's extensive retail network and award-winning retail experience.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 12:48 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.